Burning Rock Biotech Ltd (BNR) has risen Monday morning, with the stock increasing 0.96% in pre-market trading to 1.05. BNR's short-term technical score of 54 indicates that the stock has traded more bullishly over the last month than 54% of stocks on the market. In the Diagnostics & Research industry, which ranks 129 out of 146 industries, the stock ranks higher than 72% of stocks. Burning Rock Biotech Ltd has risen 7.22% over the past month, closing at $0.98 on October 2. During this period of time, the stock fell as low as $0.90 and as high as $1.17. BNR has an average analyst recommendation of Sell. The company has an average price target of $0.90.
BNR has an Overall Score of 31. Find out what this means to you and get the rest of the rankings on BNR!